IVOSIDENIB vs JAKAFI: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IVOSIDENIB vs JAKAFI: Safety Overview
| Metric | IVOSIDENIB | JAKAFI |
|---|---|---|
| Total FAERS Reports | 1,695 | 1,749 |
| Deaths Reported | 121 | 152 |
| Death Rate | 7.1% | 8.7% |
| Hospitalizations | 505 | 214 |
| Average Patient Age | 67.9 yrs | 70.6 yrs |
| % Female Patients | 47.9% | N/A |
| FDA Approval Date | Jul 20, 2018 | N/A |
| Manufacturer | Servier Pharmaceutical LLC | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |